Chemotherapy with etoposide, doxorubicin, cisplatin, 5-fluorouracil, and leucovorin for patients with advanced hepatocellular carcinoma

[1]  Yoon-Koo Kang,et al.  Randomized phase III trial of sorafenib versus placebo in patients with advanced hepatocellular carcinoma (HCC) , 2007 .

[2]  H. Ueno,et al.  A phase II trial of continuous infusion of 5‐fluorouracil, mitoxantrone, and cisplatin for metastatic hepatocellular carcinoma , 2005, Cancer.

[3]  Joon-Oh Park,et al.  Phase II study of doxorubicin and cisplatin in patients with metastatic hepatocellular carcinoma , 2004, Cancer Chemotherapy and Pharmacology.

[4]  T. Kogure,et al.  The efficacy of the combination therapy of 5-fluorouracil, cisplatin and leucovorin for hepatocellular carcinoma and its predictable factors , 2004, Cancer Chemotherapy and Pharmacology.

[5]  K. Kiura,et al.  Combination chemotherapy with continuous 5-fluorouracil and low-dose cisplatin infusion for advanced hepatocellular carcinoma. , 2003, Anticancer research.

[6]  M. Fung,et al.  Gemcitabine and doxorubicin for the treatment of patients with advanced hepatocellular carcinoma: a phase I-II trial. , 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

[7]  S. Pignata,et al.  Hepatocellular Carcinoma: Systemic Treatments , 2002, Journal of clinical gastroenterology.

[8]  P. Brissot,et al.  Treatment of hepatocellular carcinoma (HCC) with systemic chemotherapy combining epirubicin, cisplatinum and infusional 5-fluorouracil (ECF regimen) , 2002, Cancer Chemotherapy and Pharmacology.

[9]  J. Prieto,et al.  Efficacy and Toxicity of Intra-Arterial Cisplatin and Etoposide for Advanced Hepatocellular Carcinoma , 2002, Oncology.

[10]  S. Paik,et al.  A case of intraductal papillary mucinous tumor of pancreas combined with early gastric cancer and MALToma of stomach. , 2002, Journal of clinical gastroenterology.

[11]  H. Ueno,et al.  Phase I and pharmacokinetic study of 5-fluorouracil administered by 5-day continuous infusion in patients with hepatocellular carcinoma , 2002, Cancer Chemotherapy and Pharmacology.

[12]  W. Curran,et al.  Common toxicity criteria: version 2.0. an improved reference for grading the acute effects of cancer treatment: impact on radiotherapy. , 2000, International journal of radiation oncology, biology, physics.

[13]  F. Izzo,et al.  A new prognostic system for hepatocellular carcinoma: A retrospective study of 435 patients , 1998, Hepatology.

[14]  S. Okada.  [Chemotherapy of hepatocellular carcinoma]. , 1998, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine.

[15]  J. Pierga,et al.  Phase II trial of doxorubicin, 5-fluorouracil, etoposide, and cisplatin in advanced or recurrent endometrial carcinoma. , 1997, Gynecologic oncology.

[16]  M. Moroni,et al.  5-Fluorouracil and d,l-leucovorin calcium are active to treat unresectable hepatocellular carcinoma patients: preliminary results of a phase II study. , 1995, Oncology.

[17]  C H Chen,et al.  [Hepatocellular carcinoma: 30 years' experience in Taiwan]. , 1992, Journal of the Formosan Medical Association = Taiwan yi zhi.

[18]  V. Swaroop,et al.  Combination Chemotherapy and Radiation for Palliation of Hepatocellular Carcinoma , 1992, American journal of clinical oncology.

[19]  Max H. Myers,et al.  Manual for Staging of Cancer , 1992 .

[20]  K. Keyomarsi,et al.  Mechanism of the cytotoxic synergism of fluoropyrimidines and folinic acid in mouse leukemic cells. , 1988, The Journal of biological chemistry.

[21]  F. Shepherd,et al.  Hepatic arterial infusion of mitoxantrone in the treatment of primary hepatocellular carcinoma. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  K. Okuda.  Early recognition of hepatocellular carcinoma , 1986, Hepatology.

[23]  Roger Williams,et al.  Induction of remission in hepatocellular carcinoma: A comparison of VP 16 with adriamycin , 1983, Cancer.

[24]  W. Looney,et al.  Solid Tumour Models for the Assessment of Different Treatment Modalities: VII: Single vs Fractionated Doses of 5-Fluorouracil on Two Solid Tumours and Their Hosts , 1978, British Journal of Cancer.

[25]  J. Minna,et al.  Adriamycin therapy in American patients with hepatocellular carcinoma. , 1977, Cancer treatment reports.

[26]  R. Peters,et al.  5‐Fluorouracil in hepatocellular carcinoma. Report of twenty‐one cases , 1977, Cancer.

[27]  J. Guerre.  [Cancer of the liver]. , 1958, Concours medical.

[28]  J. Doroshow,et al.  5-Fluorouracil and high-dose calcium leucovorin for hepatocellular carcinoma: a phase II trial. , 1995, Cancer investigation.

[29]  A. Miller,et al.  Reporting results of cancer treatment , 1981, Cancer.